A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension

Clinical Pharmacology Advances and Applications ◽

10.2147/cpaa.s171735 ◽

2018 ◽

Vol Volume 10 ◽

pp. 89-99

Author(s):

Yan Li ◽

Liangang Liu ◽

Lian Huang ◽

Xiaomin Wang ◽

Matthew Hoffmann ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Healthy Subjects ◽

Food Effect ◽

Open Label ◽

Liquid Suspension ◽

Oral Liquid ◽

Randomized Crossover Study

Download Full-text

326 Co-administration of a CYP3A4 inhibitor (ketoconazole) increased the bioavailability of CS-7017 but did not affect tolerability: results from an open-label, phase I, two-way crossover study in healthy subjects

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)72033-4 ◽

2010 ◽

Vol 8 (7) ◽

pp. 104-105

Author(s):

G. Senaldi ◽

H. Zahir ◽

L. He ◽

J.C. Rasmussen ◽

K. Liu ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Healthy Subjects ◽

Cyp3a4 Inhibitor ◽

Open Label ◽

Open Label Phase

Download Full-text

A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers

SpringerPlus ◽

10.1186/2193-1801-2-236 ◽

2013 ◽

Vol 2 (1) ◽

Cited By ~ 41

Author(s):

Colin Stott ◽

Linda White ◽

Stephen Wright ◽

Darren Wilbraham ◽

Geoffrey Guy

Keyword(s):

Phase I ◽

Crossover Study ◽

Healthy Volunteers ◽

Open Label ◽

Randomized Crossover Study

Download Full-text

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2351-2 ◽

2013 ◽

Vol 73 (1) ◽

pp. 213-217 ◽

Cited By ~ 2

Author(s):

Yi-Lin Chiu ◽

Patricia LoRusso ◽

Balakrishna Hosmane ◽

Justin L. Ricker ◽

Walid Awni ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Solid Tumors ◽

Open Label ◽

Randomized Crossover Study

Download Full-text

An open-label, randomized, crossover study of the relative bioavailability of desvenlafaxine after oral administration of extended-release venlafaxine and sustained-release desvenlafaxine succinate in healthy subjects

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2004.12.222 ◽

2005 ◽

Vol 77 (2) ◽

pp. P86-P86 ◽

Cited By ~ 1

Author(s):

A NICHOLS ◽

A PATAT ◽

S BAIRDBELLAIRE ◽

J BEHRLE ◽

P CHRETIEN

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Crossover Study ◽

Healthy Subjects ◽

Extended Release ◽

Relative Bioavailability ◽

Open Label ◽

Randomized Crossover Study

Download Full-text

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1732-7 ◽

2011 ◽

Vol 68 (6) ◽

pp. 1619-1628 ◽

Cited By ~ 24

Author(s):

Suzanne Leijen ◽

Patricia M. M. B. Soetekouw ◽

T. R. Jeffry Evans ◽

Marianne Nicolson ◽

Jan H. M. Schellens ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Solid Tumors ◽

Advanced Solid Tumors ◽

Open Label ◽

Presence And Absence ◽

Randomized Crossover Study

Download Full-text

Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open‐Label Randomized Crossover Study

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.634 ◽

2018 ◽

Vol 8 (4) ◽

pp. 549-558

Author(s):

Song Ren ◽

David W. Boulton

Keyword(s):

Crossover Study ◽

Healthy Subjects ◽

Pharmacokinetic Interaction ◽

Interaction Study ◽

Open Label ◽

Aluminum Hydroxides ◽

Randomized Crossover Study

Download Full-text

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a  regimen of stiripentol, clobazam, and valproate in healthy subjects

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp203276 ◽

2019 ◽

Vol 57 (01) ◽

pp. 11-19 ◽

Cited By ~ 21

Author(s):

Brooks Boyd ◽

Steven Smith ◽

Arnold Gammaitoni ◽

Bradley S. Galer ◽

Gail M. Farfel

Keyword(s):

Single Dose ◽

Drug Interaction ◽

Phase I ◽

Crossover Study ◽

Healthy Subjects ◽

Oral Solution ◽

Open Label ◽

Drug Drug Interaction

Download Full-text

325 Food does not affect the pharmacokinetics of CS-7017 in healthy subjects: results from an open label, phase I, two-treatment, three-period, crossover study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)72032-2 ◽

2010 ◽

Vol 8 (7) ◽

pp. 104

Author(s):

R. Scheyer ◽

H. Zahir ◽

R. Luo ◽

L. He ◽

R. Noveck ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Healthy Subjects ◽

Open Label ◽

Open Label Phase

Download Full-text

Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.07.010 ◽

2020 ◽

Vol 42 (9) ◽

pp. 1778-1786

Author(s):

Hongjie Qian ◽

Xue Wu ◽

Qian Chen ◽

Tingting Li ◽

Wei Wang ◽

...

Keyword(s):

Single Dose ◽

Phase I ◽

Crossover Study ◽

Healthy Subjects ◽

Open Label ◽

Pharmacokinetic Properties

Download Full-text

Phase I, Open-Label, Randomized, Crossover Study Evaluating the Effects of Linifanib on Qtc Intervals in Patients with Solid Tumors

Annals of Oncology ◽

10.1016/s0923-7534(20)33069-6 ◽

2012 ◽

Vol 23 ◽

pp. ix173

Author(s):

Y. Chiu ◽

P.M. LoRusso ◽

J.L. Ricker ◽

X. Li ◽

R. Pradhan ◽

...

Keyword(s):

Phase I ◽

Crossover Study ◽

Solid Tumors ◽

Open Label ◽

Randomized Crossover Study

Download Full-text

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension

326 Co-administration of a CYP3A4 inhibitor (ketoconazole) increased the bioavailability of CS-7017 but did not affect tolerability: results from an open-label, phase I, two-way crossover study in healthy subjects

A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

An open-label, randomized, crossover study of the relative bioavailability of desvenlafaxine after oral administration of extended-release venlafaxine and sustained-release desvenlafaxine succinate in healthy subjects

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors

Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open‐Label Randomized Crossover Study

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects

325 Food does not affect the pharmacokinetics of CS-7017 in healthy subjects: results from an open label, phase I, two-treatment, three-period, crossover study

Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects

Phase I, Open-Label, Randomized, Crossover Study Evaluating the Effects of Linifanib on Qtc Intervals in Patients with Solid Tumors

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a  regimen of stiripentol, clobazam, and valproate in healthy subjects